Phase 2 Invasive Breast Cancer Clinical Trials

8 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 18 of 8 trials

Recruiting
Phase 2

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

Breast CancerBreast CarcinomaBreast Neoplasm+34 more
University of California, Davis86 enrolled1 locationNCT06268665
Recruiting
Phase 2

(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

Breast NeoplasmsInvasive Breast Cancer
Atossa Therapeutics, Inc.87 enrolled15 locationsNCT05607004
Recruiting
Phase 2

Sacituzumab Govitecan In TNBC

Invasive Breast Cancer
Massachusetts General Hospital260 enrolled5 locationsNCT04230109
Recruiting
Phase 2

TRUDI: TDXD+Durva in HER2+/Low IBC

Breast CancerInvasive Breast CancerHER2-positive Breast Cancer+2 more
Filipa Lynce, MD63 enrolled3 locationsNCT05795101
Recruiting
Phase 2

Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer

Breast CancerDuctal Carcinoma in SituInvasive Breast Cancer
Yonsei University47 enrolled1 locationNCT06677944
Completed
Phase 2

A phase II study evaluating a decision aid for women considering neoadjuvant systemic therapy for operable invasive breast cancer (ANZ 1301 DOMINO)

Operable invasive breast cancer
Breast Cancer Trials50 enrolled4 locationsACTRN12614001267640
Completed
Phase 2

ANZ 1401 (ELIMINATE) Randomised phase II trial of neoadjuvant chemotherapy +/- concurrent aromatase inhibitor endocrine therapy to down-stage large oestrogen receptor positive breast cancer

Grade 2/3 ER-positive, HER2-negative Invasive Breast Cancer > 20 mm
Breast Cancer Trials134 enrolled1 locationACTRN12614000515695
Completed
Phase 2

ANZ 0301 / BCIRG 103 (1839 IL / 0219) : Presurgical Study Evaluating IRESSA

Invasive Breast Cancer
AstraZeneca Pharmaceuticals59 enrolled1 locationACTRN12607000013460